The upcoming American Society of Clinical Oncology (ASCO) meeting in 2024 will focus on the theme ‘The Art and Science of Cancer Care: From Comfort to Cure’. More than 40,000 oncology professionals are expected to attend the three-day event in Chicago. The conference will highlight advancements in lung cancer treatments, including targeted therapies, immunotherapy, and neoadjuvant immunotherapies. Research on improving patient outcomes and quality of life will also be presented. Key drugs such as Nivolumab, pembrolizumab, and atezolizumab will be discussed, along with new approaches to early detection and care for patients with advanced disease..exciting developments in lung cancer research.
Source link
ASCO Meeting preview – A focus on Lung Cancer in Chicago and new treatments
